nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
April 25, 2024 09:29 ET | Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm
baylor-logo-wire-1200x628.jpg
Using AI to Improve Diagnosis of Rare Genetic Disorders
April 25, 2024 09:19 ET | Baylor Genetics
Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to
American Kidney Fund
American Kidney Fund Launches National Kidney Health Equity Media Campaign
April 25, 2024 09:01 ET | American Kidney Fund
ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- As part of its longstanding commitment to kidney health equity, the American Kidney Fund (AKF) has launched a national media campaign aimed at...
Exploring a mother-child patient population for which mothers received a flu vaccine during pregnancy to understand virus protection for the child after birth using Truveta Studio
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
April 25, 2024 09:00 ET | Truveta
BELLEVUE, Wash., April 25, 2024 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of Saving Lives with Data, announced today the largest and most complete mother-child electronic health record...
Polaris Logo - v2.png
Acute Repetitive Seizures Market Predicted to Reach USD 7.94 Billion By 2032, With a Growth of 11.9% CAGR: Polaris Market Research
April 25, 2024 08:33 ET | Polaris Market Research & Consulting LLP
New York, NY, April 25, 2024 (GLOBE NEWSWIRE) -- According to Polaris Market Research, the global acute repetitive seizures market size and share was valued at USD 2.90 billion in 2023 and is...
starton.png
Starton Therapeutics Announces Enrollment Completion for STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma
April 25, 2024 08:30 ET | Starton Therapeutics
Phase 1b data in the first 50% of patients reflect the responses seen in animals and may suggest superiority in both safety and efficacy when compared to oral Revlimid®Anticipate FDA alignment and...
MnM_logo_TM_JPG.JPG
Clinical Communication & Collaboration Market is Expected to Reach $4.8 billion | MarketsandMarkets™
April 25, 2024 08:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, April 25, 2024 (GLOBE NEWSWIRE) -- Clinical Communication & Collaboration market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $4.8 billion...
UNITY color transp BG.jpg
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
April 25, 2024 08:00 ET | Unity Biotechnology, Inc.
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
BioVie Logo.jpg
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
April 25, 2024 08:00 ET | BioVie, Inc.
“Bezisterim” has been approved as the non-proprietary name for NE3107Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation ...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
April 25, 2024 08:00 ET | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...